{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:04:39Z","timestamp":1778583879488,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>In this study, we analyzed the consumption trends of antihypertensives in Morocco during the 1991\u20132010 period and the impacts after the institution of Mandatory Health Insurance and the marketing of generic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used sales data from the Moroccan subsidiary of IMS Health \u201cIntercontinental Marketing Service\u201d. The consumption volumes were converted into defined daily doses (DDDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 1991 and 2010, outpatient consumption of antihypertensives went from 4.37 to 23.14 DDD\/1000 inhabitants\/day, a 5.30\u2010fold increase. In 2010, calcium channel blockers (CCBs) and angiotensin converting enzyme inhibitors (ACEI) were the most consumed (4.97 DDD\/1000 inhabitants\/day) for each one, followed by diuretics (4.20 DDD\/1000 inhabitants\/day). The most consumed products were amlodipine (4.27 DDD\/1000 inhabitants\/day) followed by ramipril (3.18 DDD\/1000 inhabitants \/day) and indapamide (1.72 DDD\/1000inhabitants\/day). Between 1991 and 2010, the consumption of generic antihypertensives went from 2% to 46%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Antihypertensive consumption increased between 1991 and 2010. However, despite the increase of generic drugs consumption, the levels of antihypertensive consumption remain lower than the needs of hypertensive patients. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3288","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T17:01:54Z","timestamp":1337014914000},"page":"1067-1073","source":"Crossref","is-referenced-by-count":5,"title":["Trends in antihypertensives use among Moroccan patients"],"prefix":"10.1002","volume":"21","author":[{"given":"G.","family":"Berrada El Azizi","sequence":"first","affiliation":[{"name":"Research Team of Pharmacoepidemiology &amp; Pharmacoeconomics. Laboratory of Pharmacology &amp; Toxicology, Faculty of Medicine &amp; Pharmacy University Mohammed V\u2010Souissi  Rabat Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ahid","sequence":"additional","affiliation":[{"name":"Research Team of Pharmacoepidemiology &amp; Pharmacoeconomics. Laboratory of Pharmacology &amp; Toxicology, Faculty of Medicine &amp; Pharmacy University Mohammed V\u2010Souissi  Rabat Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ghanname","sequence":"additional","affiliation":[{"name":"Research Team of Pharmacoepidemiology &amp; Pharmacoeconomics. Laboratory of Pharmacology &amp; Toxicology, Faculty of Medicine &amp; Pharmacy University Mohammed V\u2010Souissi  Rabat Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belaiche","sequence":"additional","affiliation":[{"name":"Pharmaceutical Industry Consultant  Casablanca Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hassar","sequence":"additional","affiliation":[{"name":"Research Team of Pharmacoepidemiology &amp; Pharmacoeconomics. Laboratory of Pharmacology &amp; Toxicology, Faculty of Medicine &amp; Pharmacy University Mohammed V\u2010Souissi  Rabat Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Cherrah","sequence":"additional","affiliation":[{"name":"Research Team of Pharmacoepidemiology &amp; Pharmacoeconomics. Laboratory of Pharmacology &amp; Toxicology, Faculty of Medicine &amp; Pharmacy University Mohammed V\u2010Souissi  Rabat Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(06)70275-6"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2009.00245.x"},{"key":"e_1_2_7_4_1","unstructured":"MathersC StevensG MascarenhasM.Global health risks: mortality and burden of disease attributable to selected major risks. Geneva Switzerland: World Health Organization;2009.http: \/\/www.who.int\/healthinfo\/global_burden_disease\/GlobalHealthRisks_report_full.pdf(accessed 3 January 2011)."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17741-1"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00013"},{"key":"e_1_2_7_7_1","unstructured":"Centre d'\u00e9tudes et de recherches d\u00e9mographiques.Projections de la population du Maroc par milieu de r\u00e9sidence 2005\u20132030. Haut\u2010commissariat au plan. Royaume du Maroc. D\u00e9cembre2007."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021716"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3281fc975a"},{"key":"e_1_2_7_12_1","unstructured":"Recommandations de Bonnes Pratiques M\u00e9dicales Affection Longue Dur\u00e9e L'hypertension art\u00e9rielle de l'adulte CIM 10: I10 code ANAM: E113 R\u00e9f ANAM: 0.3.88.01; AVRIL2010.http: \/\/www.assurancemaladie.ma\/upload\/document\/hypertension\u2010text.pdf"},{"key":"e_1_2_7_13_1","unstructured":"Politique de sante de l'enfant au Maroc analyse de situation.Royaume du Maroc minist\u00e8re de la sante. Direction de la Population. Octobre2005."},{"key":"e_1_2_7_14_1","unstructured":"Office marocain de la propri\u00e9t\u00e9 industrielle et commercialehttp: \/\/www.ompic.org.ma\/ompic_fr_99.shtm(accessed 10 January 2012)."},{"key":"e_1_2_7_15_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b05374 28 chaoual 1426 (01\u201012\u20102005): 803\u2010ISSN: 0851\u20131217. Version fran\u00e7aise.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Fr\/2005\/BO_5374_fr.pdf. (accessed 25 December 2011)."},{"key":"e_1_2_7_16_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b05400 1ersafar 1427 (02\u201003\u20102006): 316\u2010ISSN: 0851\u20131217. Version fran\u00e7aise.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Fr\/2006\/BO_5400_fr.pdf. (accessed 29 December 2011)."},{"key":"e_1_2_7_17_1","unstructured":"Etude sur le financement des soins de sant\u00e9 au Maroc Organisation Mondiale de la sant\u00e9 rapport final novembre 2007 page 38\u201357.http: \/\/gis.emro.who.int\/HealthSystemObservatory\/PDF\/Health%20Care%20Financing\/Mapping%20Health%20care%20Financing%20Morocco.pdf(accessed 10 August 2011)."},{"key":"e_1_2_7_18_1","unstructured":"D\u00e9penses des m\u00e9nages in\u00e9galit\u00e9s pauvret\u00e9 et vuln\u00e9rabilit\u00e9: 1960\u20132007.Haut Commissariat au Plan. Royaume du Maroc."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199912000-00012"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000242"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7000.293"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/20.1.61"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06316-2"},{"key":"e_1_2_7_24_1","unstructured":"Maroc perspective \u00e9conomique en Afrique \u00a9 BAfD\/OCDE2008page:471.http: \/\/www.oecd.org\/dataoecd\/5\/12\/40570729.pdf(accessed 10 August 2011)."},{"key":"e_1_2_7_25_1","unstructured":"D\u00e9cret n\u00b0 2\u201005\u2010733 du 11 joumada II 1426 (18 juillet 2005) pris pour l'application de la loi n\u00b0 65\u201300 portant code de la couverture m\u00e9dicale de base.http: \/\/www.assurancemaladie.ma\/upload\/document\/decret733.pdf(accessed 20 July 2011)."},{"key":"e_1_2_7_26_1","unstructured":"Agence National de l'Assurance de Maladie. ANAM.http: \/\/www.anam.ma\/upload\/document\/GMR_6_08_DCI.pdf(accessed 20 January 2012)."},{"key":"e_1_2_7_27_1","unstructured":"Annuaire statistique.Haut Commissariat au Plan. Comptes de la nation.2010"},{"key":"e_1_2_7_28_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b05219 18 Rabiae al khar 1425 (07\u20106\u20102004): 2508\u2010 ISSN: 0851\u20131195. Version arabe.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Ar\/2004\/BO_5219_ar.pdf(Accessed 14 December 2011)."},{"key":"e_1_2_7_29_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b05649 17 Rajab 1429 (21\u201006\u20102008): 2233\u2010 ISSN: 0851\u20131195. Version arabe.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Ar\/2008\/BO_5649_Ar.pdf. (Accessed 14 December 2011)."},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2008035"},{"issue":"6","key":"e_1_2_7_31_1","first-page":"553","article-title":"Methods for the measurement of drug consumption: Application to antibiotics. [in French]","volume":"60","author":"Sommet A","year":"2005","journal-title":"Therapie"},{"key":"e_1_2_7_32_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology ATC classification index with DDDs 2011. Oslo2010."},{"key":"e_1_2_7_33_1","unstructured":"Haut Commissariat au Plan\u2010Maroc (HCP).http: \/\/www.hcp.ma. (Accessed 29 December 2010)."},{"key":"e_1_2_7_34_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b04084 21rejeb 1411(06\u201002\u20101991): 39\u2010ISSN: 0851\u20131217. Version fran\u00e7aise.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Fr\/1991\/BO_4084_fr.PDF. (Accessed 29 December 2010)."},{"key":"e_1_2_7_35_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b04808 bis 26 rabii I 1421 (29\u201006\u20102000): 599\u2010 ISSN: 0851\u20131217. Version fran\u00e7aise.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Fr\/2000\/BO_4808\u2010bis_fr.PDF. (Accessed 29 December 2010)."},{"key":"e_1_2_7_36_1","unstructured":"Secr\u00e9tariat g\u00e9n\u00e9ral du gouvernement.Bulletin officiel N\u00b05654 5 Chaabane 1429 (07\u20108\u20102008): 551\u2010 ISSN: 0851\u20131217. Version fran\u00e7aise.http: \/\/www.sgg.gov.ma\/BO\/bulletin\/Fr\/2008\/BO_5654_Fr.pdf. (Accessed 29 December 2010)."},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7101.154"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540330061036"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7210.630"},{"key":"e_1_2_7_41_1","unstructured":"Recommandations de Bonnes Pratiques M\u00e9dicales Affection Longue Dur\u00e9e L'hypertension art\u00e9rielle de l'adulte CIM 10: I10 code ANAM: E113 R\u00e9f ANAM: 0.3.88.01; AVRIL2010.http: \/\/www.assurancemaladie.ma\/upload\/document\/hypertension\u2010text.pdf."},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000249685.58370.28"},{"key":"e_1_2_7_43_1","first-page":"CD002003","article-title":"Beta\u2010blockers for hypertension","volume":"1","author":"Wiysonge CS","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328333146d"},{"key":"e_1_2_7_45_1","unstructured":"ViensG LevesqueK ChahwakilianP et al.Evolution compar\u00e9e de la consommation de m\u00e9dicaments dans 5 pays europ\u00e9ens entre 2000 et 2004: analyse de 7 classes pharmaco\u2010th\u00e9rapeutiques. \u00c9cole sup\u00e9rieure des sciences \u00e9conomiques et commerciales\u2009\u00ab\u2009ESSEC \u00bb: Centre de Recherche 2007. F\u00e9vrier."},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.26719\/2009.15.4.827"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00013"},{"key":"e_1_2_7_48_1","unstructured":"BourkadiA ZouiteneM HariryK et al.Rapport de la Mission d'Information sur le Prix du M\u00e9dicament au Maroc. Commission des Finances et du D\u00e9veloppement Economique de la Chambre des Repr\u00e9sentants le 3 Novembre2009."},{"key":"e_1_2_7_49_1","unstructured":"Consommation et d\u00e9penses de m\u00e9dicaments: comparaison des pratiques fran\u00e7aises et europ\u00e9ennes. Caisse nationale de l'Assurance Maladie\u2009\u00ab\u2009CNAM\u2009\u00bb\u2009\u2013Point d'information mensuel 19 octobre2007."},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000200"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3288","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:15:32Z","timestamp":1695478532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1002\/pds.3288"],"URL":"https:\/\/doi.org\/10.1002\/pds.3288","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}